MS vs CPAY
By Alex · Tickerpine
Morgan Stanley vs Corpay, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | CPAY |
|---|---|---|
| Price | $217.64 | $409.68 |
| Market cap | $342.13B | $26.90B |
| P/E ratio | 17.4 | 24.7 |
| ROE | 17.97% | 29.22% |
| Profit margin | 25.90% | 22.72% |
| Revenue growth | 28.00% | 21.50% |
| Dividend yield | 2.14% | — |
| Beta | 1.21 | 0.87 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs CPAY in plain English
- MS is the bigger company — about 12.7× the market cap of CPAY.
- MS is cheaper on earnings (P/E 17.4 vs 24.7).
- CPAY earns a higher return on equity (29% vs 18%).
- MS is growing revenue faster (28% vs 22%).
- MS pays a dividend (2.14%) while the other effectively doesn't.
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
CPAY return calculator
See what $1,000 in Corpay, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.